B. van Ravenzwaay

3.4k total citations
55 papers, 2.2k citations indexed

About

B. van Ravenzwaay is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Dermatology. According to data from OpenAlex, B. van Ravenzwaay has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Health, Toxicology and Mutagenesis, 13 papers in Molecular Biology and 9 papers in Dermatology. Recurrent topics in B. van Ravenzwaay's work include Effects and risks of endocrine disrupting chemicals (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Contact Dermatitis and Allergies (7 papers). B. van Ravenzwaay is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Contact Dermatitis and Allergies (7 papers). B. van Ravenzwaay collaborates with scholars based in Germany, United States and United Kingdom. B. van Ravenzwaay's co-authors include Robert Landsiedel, Edgar Leibold, Eric Fabian, Lan Ma‐Hock, Armin Gamer, Karin Wiench, Wendel Wohlleben, Hennicke Kamp, Volker Strauss and Katharina Guth and has published in prestigious journals such as British Journal of Cancer, Carcinogenesis and Food and Chemical Toxicology.

In The Last Decade

B. van Ravenzwaay

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. van Ravenzwaay Germany 25 631 628 411 368 263 55 2.2k
Eric Fabian Germany 27 464 0.7× 540 0.9× 638 1.6× 516 1.4× 262 1.0× 88 2.6k
Gerhard J. Nohynek France 24 709 1.1× 610 1.0× 413 1.0× 806 2.2× 267 1.0× 43 3.0k
Armin Gamer Germany 18 561 0.9× 517 0.8× 127 0.3× 492 1.3× 212 0.8× 34 1.7k
Edgar Leibold Germany 19 176 0.3× 397 0.6× 370 0.9× 254 0.7× 134 0.5× 58 1.3k
Darrell R. Boverhof United States 23 467 0.7× 702 1.1× 443 1.1× 169 0.5× 231 0.9× 40 2.1k
Jian Yan United States 24 644 1.0× 451 0.7× 730 1.8× 131 0.4× 184 0.7× 59 2.0k
S. Wijnhoven Netherlands 20 1.2k 1.9× 390 0.6× 743 1.8× 60 0.2× 392 1.5× 32 2.6k
Choudari Kommineni United States 18 473 0.7× 360 0.6× 371 0.9× 120 0.3× 260 1.0× 36 1.9k
Yuko Ibuki Japan 28 642 1.0× 455 0.7× 798 1.9× 176 0.5× 330 1.3× 102 2.3k
Mary D. Boudreau United States 26 1.1k 1.8× 208 0.3× 718 1.7× 93 0.3× 469 1.8× 41 2.8k

Countries citing papers authored by B. van Ravenzwaay

Since Specialization
Citations

This map shows the geographic impact of B. van Ravenzwaay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. van Ravenzwaay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. van Ravenzwaay more than expected).

Fields of papers citing papers by B. van Ravenzwaay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. van Ravenzwaay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. van Ravenzwaay. The network helps show where B. van Ravenzwaay may publish in the future.

Co-authorship network of co-authors of B. van Ravenzwaay

This figure shows the co-authorship network connecting the top 25 collaborators of B. van Ravenzwaay. A scholar is included among the top collaborators of B. van Ravenzwaay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. van Ravenzwaay. B. van Ravenzwaay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gant, Timothy W., Scott S. Auerbach, Martin von Bergen�, et al.. (2023). Applying genomics in regulatory toxicology: a report of the ECETOC workshop on omics threshold on non-adversity. Archives of Toxicology. 97(8). 2291–2302. 10 indexed citations
2.
Kamp, Hennicke, et al.. (2021). Influence of pregnancy and non-fasting conditions on the plasma metabolome in a rat prenatal toxicity study. Archives of Toxicology. 95(9). 2941–2959. 3 indexed citations
3.
Kamp, Hennicke, et al.. (2021). Succinate dehydrogenase inhibitors: in silico flux analysis and in vivo metabolomics investigations show no severe metabolic consequences for rats and humans. Food and Chemical Toxicology. 150. 112085–112085. 10 indexed citations
4.
Ramı́rez, Tzutzuy, Alexander Strigun, Erik Peter, et al.. (2017). Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells. Archives of Toxicology. 92(2). 893–906. 121 indexed citations
5.
Kauffmann, Hans-Martin, Hennicke Kamp, Regine Fuchs, et al.. (2017). Framework for the quality assurance of ’omics technologies considering GLP requirements. Regulatory Toxicology and Pharmacology. 91. S27–S35. 25 indexed citations
6.
Guth, Katharina, J.E. Riviere, James D. Brooks, et al.. (2014). In silico models to predict dermal absorption from complex agrochemical formulations. SAR and QSAR in environmental research. 25(7). 565–588. 13 indexed citations
7.
Ravenzwaay, B. van, G. Montoya, Eric Fabian, et al.. (2014). The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective. Toxicology Letters. 227(1). 20–28. 29 indexed citations
8.
Guth, Katharina, Monika Schäfer‐Korting, Eric Fabian, et al.. (2013). Flow-through versus static design for dermal absorption experiments in vitro. Toxicology Letters. 221. S187–S187. 1 indexed citations
9.
Montoya, G., Volker Strauss, Eric Fabian, et al.. (2013). Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. Toxicology Letters. 225(2). 240–251. 29 indexed citations
10.
Ravenzwaay, B. van, Martina Dammann, Roland Buesen, Burkhard Flick, & Steffen Schneider. (2012). The threshold of toxicological concern for prenatal developmental toxicity in rabbits and a comparison to TTC values in rats. Regulatory Toxicology and Pharmacology. 64(1). 1–8. 14 indexed citations
11.
Strauss, Volker, W. Mellert, J. Wiemer, et al.. (2012). Increased toxicity when fibrates and statins are administered in combination – A metabolomics approach with rats. Toxicology Letters. 211(2). 187–200. 22 indexed citations
13.
Kolle, Susanne N., et al.. (2010). In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays. Toxicology in Vitro. 24(7). 2030–2040. 53 indexed citations
14.
Landsiedel, Robert, Lan Ma‐Hock, B. van Ravenzwaay, et al.. (2010). Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations. Nanotoxicology. 4(4). 364–381. 102 indexed citations
15.
Ravenzwaay, B. van, et al.. (2008). Comparing fate and effects of three particles of different surface properties: Nano-TiO2, pigmentary TiO2 and quartz. Toxicology Letters. 186(3). 152–159. 117 indexed citations
16.
Ma‐Hock, Lan, Armin Gamer, Robert Landsiedel, et al.. (2007). Generation and Characterization of Test Atmospheres with Nanomaterials. Inhalation Toxicology. 19(10). 833–848. 58 indexed citations
17.
Fabian, Eric, Robert Landsiedel, Lan Ma‐Hock, et al.. (2007). Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Archives of Toxicology. 82(3). 151–157. 304 indexed citations
18.
Welsch, Frank, et al.. (2005). Workshop: Influence of maternal toxicity in studies on developmental toxicity. Regulatory Toxicology and Pharmacology. 43(1). 114–115. 4 indexed citations
19.
Mellert, W., et al.. (2003). Detection of endocrine-modulating effects of the antithyroid acting drug 6-propyl-2-thiouracil in rats, based on the “Enhanced OECD Test Guideline 407”. Regulatory Toxicology and Pharmacology. 38(3). 368–377. 35 indexed citations
20.
Charles, Jeffrey M., et al.. (2001). Developmental Toxicity Studies in Rats and Rabbits on 2,4-Dichlorophenoxyacetic Acid and Its Forms. Toxicological Sciences. 60(1). 121–131. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026